Article
Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C.
Journal of virology - 4 May 2020
Tartaglia Lawrence J, Gupte Siddhant, Pastores Kevin C, Trott Sebastien, Abbink Peter, Mercado Noe B, Li Zhenfeng, Liu Po-Ting, Borducchi Erica N, Chandrashekar Abishek, Bondzie Esther Apraku, Hamza Venous, Kordana Nicole, Mahrokhian Shant, Lavine Christy L, Seaman Michael S, Li Hui, Shaw George M, Barouch Dan H
Abstract excerpt
Simian-human immunodeficiency virus (SHIV) infection of rhesus monkeys is an important preclinical model for human immunodeficiency virus type 1 (HIV-1) vaccines, therapeutics, and cure strategies. SHIVs have been optimized by incorporating HIV-1 Env residue 375 mutations that mimic the bulky or hydrophobic residues typically found in simian immunodeficiency virus (SIV) Env to improve rhesus CD4 binding. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
